Gst-hg131 project approved by the board of directors of GST
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Guangshengtang (300436) announced in the morning on February 3 that the board of directors of the company had deliberated and passed the proposal on deliberating the project initiation report of gst-hg131 project and authorizing the management to sign relevant R & D cooperation agreements on February 2, 2016 According to the announcement, the drug is a hepatitis B treatment drug, belonging to chemical drug 1, which is used to treat hepatitis B infection It is a part of the combination of drugs, aiming to activate the immune system of patients and achieve the purpose of functional cure of hepatitis B The company noted that the drug is a new drug, with large R & D investment, long cycle and large uncertainty of approval Therefore, the majority of investors are invited to pay attention to the investment risk.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
